PTC Therapeutics, Inc. (NASDAQ:PTCT) Director Jerome B. Zeldis Sells 20,000 Shares of Stock
PTC Therapeutics, Inc. (NASDAQ:PTCT – Get Free Report) Director Jerome B. Zeldis sold 20,000 shares of the company’s stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $38.24, for a total transaction of $764,800.00. Following the transaction, the director now owns 14,500 shares of the […]
More Stories
Vistry Group (LON:VTY) Shares Down 16.1% – Here’s What Happened
Vistry Group PLC (LON:VTY – Get Free Report)’s stock price fell 16.1% during trading on Wednesday . The company traded...
Transcontinental (TSE:TCL.B) Stock Price Crosses Above 50 Day Moving Average – Time to Sell?
Transcontinental Inc. (TSE:TCL.B – Get Free Report) passed above its fifty day moving average during trading on Monday . The...
Direxion Daily Real Estate Bear 3X Shares (NYSEARCA:DRV) Stock Cross Above 50-Day Moving Average – Here’s Why
Direxion Daily Real Estate Bear 3X Shares (NYSEARCA:DRV – Get Free Report)’s stock price crossed above its 50 day moving...
Fifth Street Asset Management (OTCMKTS:FSAM) Share Price Passes Above 50 Day Moving Average – Time to Sell?
Fifth Street Asset Management Inc. (OTCMKTS:FSAM – Get Free Report)’s stock price crossed above its fifty day moving average during...
Pollard Banknote (TSE:PBL) Shares Cross Below Fifty Day Moving Average – Time to Sell?
Pollard Banknote Limited (TSE:PBL – Get Free Report)’s share price crossed below its 50-day moving average during trading on Monday...
ClearBridge Large Cap Growth ESG ETF (NASDAQ:LRGE) Plans Dividend Increase – $0.13 Per Share
ClearBridge Large Cap Growth ESG ETF (NASDAQ:LRGE – Get Free Report) declared a dividend on Tuesday, December 24th,NASDAQ Dividends reports....